Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infusion therapy is currently emerging market as the therapy are ideally refers to the administration of solutions or medications via the IV, subcutaneous, intraosseous, and intraspinal route. The infusion therapy is ideally a process where the patient receive medication via different administration. Home infusion therapy further offer patient comprehensive and innovative source for health care in the comfort of their home. It acts as a safe and effective alternative to inpatient care for variety of therapies and diseases. Home administered infusion therapy includes anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition which management of diseases. The growing demand for various products in home infusion therapy is expected to drive the market growth during the estimated time period.
The global home infusion therapy market is majorly driven by growing geriatric population, advancements in technology and rising prevalence of chronic disease. The increasing prevalence of diseases, chronic medical ailment such as cancer, diabetes has led the rising requirement for home infusion therapy globally. Besides, the demand for market is majorly due to growing cases of HAI (hospital acquired infections) which has further created ample of new growth opportunity for market. Besides, COVID-19 spread, and requirement for treatment in various diseases, COVID-19 has boosted the market growth to huge extend. Likewise, availability of cost effective and user friendly home infusion therapy has fuelled the growth of market. The rising preference for home infusion therapy worldwide is expected to drive the market growth during the estimated time period.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the home infusion therapy market. In addition, complete analysis of changes on home infusion therapy market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The home infusion therapy market comprises of different market segment like product, application and geography.
The home infusion therapy is available in market according different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. In the global home infusion therapy market by product, infusion pump is expected to gain major market share attributing to its ability to deliver fluids in large or small amounts and can be widely used to deliver nutrients or medication. Besides, the growing demand for syringe infusion is due to its gradual administer specific amount of fluids for use in biomedical research. Likewise, ambulatory infusion pump is widely having growing demand owing features like it helps in slowly deliver the medicine like chemotherapy or antibiotics into the patient’s body. Likewise, intravenous sets, followed by IV cannulas and needleless connectors are likely to contribute healthy growth in the market during the estimated time period.
The home infusion therapy market finds its major application in anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition and others. The anti-infective is expected to dominate in the market during the forecast period owing to its major use in different procedure for the administration of antifungal and antibiotic drugs. Besides, the segment is majorly used to prevent or treat infection including antibacterial, antiviral, antifungal and antiparasitic medications. Similarly, chemotherapy is having increasing demand for home infusion therapy as helps for proper management of infusion medication which has further created driving demand for market worldwide.
The global home infusion therapy market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is expected to dominate in the market during the estimated time period owing to presence of advanced healthcare facilities, increasing adoption of technology based therapy. Likewise, growing research and development, product innovation has fuelled the demand for market. In addition, burden of different diseases has led the manufacturer with new growth opportunity in market. Likewise, shifting trends and preference for home infusion therapy is boosting the market growth. In addition, Europe is expected to witness growth at specific growth rate in upcoming years due to increasing hospital procedure and large base of geriatric consumers for home infusion therapy market.
The key players in home infusion therapy market are B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Hospira, Inc, ICU Medical, Inc, Caesarea Medical Electronics Ltd, Baxter International Inc, JMS Co. Ltd, Smiths Medical, Eli Lilly and Company, Fresenius Kabi, Terumo Corporation and Cosmed among others.
April 2021 : Medtronic had unveiled its extended infusion set, the first set that can be worn to deliver insulin for up to seven days in selected European countries. Infusion sets are tubing that provides insulin to the body form a pump and then usually need to be changed every few days. The extended infusion set doubles the times a set can be worn, it allows user to safely stay on insulin pump therapy with fewer interruption and insertion while providing improved convince for diabetes management routines.
April 2020 : B.Braun Medical Inc had announced the US Food and Drug administration issued Emergency use authorization of B. Braun’s perfusor space syringe infusion pump, infusomat space volumetric infusion pump and outlook ES pump system for use in the tracheal delivery of continuous nebulized medication into nebulizer to treat patient of all ages with or suspended of having Coronavirus diseases.
October 2017 : BioScrip, Inc had announced that it can now dispense and administer Radicava (edaravone), the first treatment option for amyotrophic lateral sclerosis(ALS) approved by the U.S. Food and Drug Administration (FDA) in more than 20 years. Radicava is commercialized in U.S. by Mitsubishi Tanabe Pharma America, Inc.
The report analyses the home infusion therapy market based on by product, application and geography. The home infusion therapy is available in market according different product including infusion pump, intravenous sets, IV cannulas, and needleless connectors. The infusion pump further includes sub segment like syringe infusion pump, ambulatory infusion pump, implantable infusion pump, insulin infusion pump and others. In the global home infusion therapy market by product, infusion pump is expected to gain major market share. The home infusion therapy market finds its major application in anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition and others. The anti-infective is expected to dominate in the market during the forecast period. The global home infusion therapy market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW).
Why to buy this report:
